GE HealthCare Technologies Inc. (NASDAQ:GEHC) Position Trimmed by AdvisorNet Financial Inc

AdvisorNet Financial Inc lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,562 shares of the company’s stock after selling 3,426 shares during the period. AdvisorNet Financial Inc’s holdings in GE HealthCare Technologies were worth $1,686,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Miracle Mile Advisors LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $240,000. Bar Harbor Wealth Management lifted its position in shares of GE HealthCare Technologies by 6.6% in the 4th quarter. Bar Harbor Wealth Management now owns 26,784 shares of the company’s stock valued at $2,094,000 after acquiring an additional 1,648 shares in the last quarter. Bridge Creek Capital Management LLC boosted its stake in GE HealthCare Technologies by 10.3% in the 4th quarter. Bridge Creek Capital Management LLC now owns 11,729 shares of the company’s stock worth $917,000 after purchasing an additional 1,092 shares during the period. Future Financial Wealth Managment LLC grew its position in GE HealthCare Technologies by 26.1% during the 4th quarter. Future Financial Wealth Managment LLC now owns 677 shares of the company’s stock worth $53,000 after purchasing an additional 140 shares in the last quarter. Finally, City State Bank raised its stake in GE HealthCare Technologies by 51.6% during the 4th quarter. City State Bank now owns 561 shares of the company’s stock valued at $44,000 after purchasing an additional 191 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.27% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI upped their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Wednesday, September 18th. Finally, Stifel Nicolaus upped their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Trading Down 1.4 %

Shares of NASDAQ:GEHC opened at $84.13 on Wednesday. GE HealthCare Technologies Inc. has a 1 year low of $71.31 and a 1 year high of $94.55. The firm has a fifty day moving average price of $82.13 and a 200 day moving average price of $84.27. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $38.44 billion, a PE ratio of 23.11, a P/E/G ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.99 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.